Search

everythinglearnresearchcommunity

for

Search:↓

The research explains how a human enzyme binds and processes its substrate, which could relate to its role in biological functions and hair loss.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

AHR ligands could treat inflammatory skin diseases.

Inhibiting ACE2 improves skin regeneration during tissue expansion.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Ghrelin and its receptors likely aren't risk factors for PCOS.

Lampreys have a functional vitamin D receptor that may help detoxify harmful substances.

The E2 protein affects gene activity in hair follicles of mice.

A new treatment for hair loss shows promise with fewer side effects.

The document concludes that the androgen receptor's structure and function are complex, affecting how it regulates genes and is involved in diseases like prostate cancer.

GLI2 increases follistatin production in human skin cells.

Pygo2 is important for early growth and progression of intestinal tumors, and could be a target for treating cancers with certain mutations.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.

OsPHR2 gene causes excessive phosphate in rice shoots, affecting plant growth and root development.

Finasteride increases CD8+ T cells in BPH tissues.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Sphingosine 1-phosphate helps control mechanical pain.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Women with hair loss have more androgen receptors in certain hair follicles.

Blocking neurosteroid production can lead to more seizures and faster epilepsy onset in rats.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.

Activating TSPO helps protect the retina from damage caused by high eye pressure in glaucoma.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.